BR112017013892A2 - métodos e dispositivos para inibir nervos ao ativar o tecido adiposo marrom - Google Patents

métodos e dispositivos para inibir nervos ao ativar o tecido adiposo marrom

Info

Publication number
BR112017013892A2
BR112017013892A2 BR112017013892-1A BR112017013892A BR112017013892A2 BR 112017013892 A2 BR112017013892 A2 BR 112017013892A2 BR 112017013892 A BR112017013892 A BR 112017013892A BR 112017013892 A2 BR112017013892 A2 BR 112017013892A2
Authority
BR
Brazil
Prior art keywords
nerves
tam
methods
devices
adipose tissue
Prior art date
Application number
BR112017013892-1A
Other languages
English (en)
Other versions
BR112017013892B1 (pt
Inventor
L. Harris Jason
C. Baynham Tamara
Original Assignee
Ethicon Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Llc filed Critical Ethicon Llc
Publication of BR112017013892A2 publication Critical patent/BR112017013892A2/pt
Publication of BR112017013892B1 publication Critical patent/BR112017013892B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0492—Patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A61N1/36034—Control systems specified by the stimulation parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/36167—Timing, e.g. stimulation onset
    • A61N1/36171—Frequency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0622—Optical stimulation for exciting neural tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

são fornecidos métodos e dispositivos para inibir nervos na ativação de tecido adiposo marrom (tam). em geral, um primeiro tipo de nervo (por exemplo, nervos simpáticos) que inerva o tam pode ser ativado enquanto ao menos um outro tipo de nervo (por exemplo, nervos parassimpáticos e/ou nervos sensoriais) que inerva o tam está sendo suprimido. um primeiro neuromodulador (por exemplo, um sinal elétrico, um produto químico, uma luz, resfriamento, etc) pode ser aplicado para ativar o primeiro tipo de nervo, e um segundo neuromodulador pode ser aplicado para inibir o ao menos um outro tipo de nervo. dessa forma, os nervos parassimpáticos e/ou os nervos sensoriais que inervam o tam podem ser inibidos quando é feita a ativação dos nervos simpáticos que inervam o tam.
BR112017013892-1A 2014-12-29 2015-12-14 Aparelho médico BR112017013892B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/584,046 US10092738B2 (en) 2014-12-29 2014-12-29 Methods and devices for inhibiting nerves when activating brown adipose tissue
US14/584,046 2014-12-29
PCT/US2015/065513 WO2016109169A1 (en) 2014-12-29 2015-12-14 Methods and devices for inhibiting nerves when activating brown adipose tissue

Publications (2)

Publication Number Publication Date
BR112017013892A2 true BR112017013892A2 (pt) 2018-01-02
BR112017013892B1 BR112017013892B1 (pt) 2022-11-08

Family

ID=55236897

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013892-1A BR112017013892B1 (pt) 2014-12-29 2015-12-14 Aparelho médico

Country Status (6)

Country Link
US (3) US10092738B2 (pt)
EP (1) EP3240606B1 (pt)
JP (1) JP6668379B2 (pt)
CN (1) CN107278161B (pt)
BR (1) BR112017013892B1 (pt)
WO (1) WO2016109169A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US11324673B2 (en) 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
JP2020503111A (ja) * 2016-12-27 2020-01-30 アヴェント インコーポレイテッド 糖尿病性末梢神経障害を処置するための物品及び方法
BR112019018191A2 (pt) * 2017-03-01 2020-06-23 Miraki Innovation Think Tank Llc Crioterapias
SG11201909305PA (en) 2017-04-05 2019-11-28 Miraki Innovation Think Tank Llc Cold slurry containment
WO2018187573A1 (en) 2017-04-05 2018-10-11 Arctic Fox Biomedical, Inc. Point of delivery cold slurry generation
US10500342B2 (en) 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
CN112088032A (zh) 2018-03-09 2020-12-15 通用电气公司 神经调节技术
US11395925B2 (en) * 2018-04-29 2022-07-26 Brian A. Gandel Device and method for inducing lypolysis in humans
WO2023052947A1 (en) 2021-09-29 2023-04-06 Cilag Gmbh International Surgical devices, systems, and methods for control of one visualization with another
WO2023052945A1 (en) 2021-09-29 2023-04-06 Cilag Gmbh International Surgical devices, systems, and methods for control of one visualization with another
WO2023052941A1 (en) 2021-09-29 2023-04-06 Cilag Gmbh International Surgical system for delivering energy to tissue in an anatomic space and monitoring a tissue parameter in a different anatomic space
WO2023052943A1 (en) 2021-09-29 2023-04-06 Cilag Gmbh International Surgical devices, systems, and methods for control of one visualization with another
US20230100698A1 (en) * 2021-09-29 2023-03-30 Cilag Gmbh International Methods for Controlling Cooperative Surgical Instruments
WO2023052935A1 (en) 2021-09-29 2023-04-06 Cilag Gmbh International Surgical devices, systems, and methods for control of one visualization with another
WO2023052937A1 (en) 2021-09-29 2023-04-06 Cilag Gmbh International Surgical system for altering the body's sensing of food

Family Cites Families (213)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596792A (en) 1981-09-04 1986-06-24 The Regents Of The University Of California Safe vaccine for hepatitis containing polymerized serum albumin
US4498843A (en) 1982-08-02 1985-02-12 Schneider Philip H Insulin infusion pump
JPS5938877A (ja) 1982-08-30 1984-03-02 Musashi Eng Kk 紙葉判別方法
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
GB8519154D0 (en) 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
GB8607312D0 (en) 1986-03-25 1986-04-30 Ici Plc Therapeutic agents
GB8714901D0 (en) 1986-07-23 1987-07-29 Ici Plc Amide derivatives
US4978338A (en) 1988-04-21 1990-12-18 Therex Corp. Implantable infusion apparatus
CH676164A5 (pt) 1988-05-28 1990-12-14 Sc Techn Dipl Ing Peter A Neuk
CN2045308U (zh) 1988-10-12 1989-10-04 路雪清 电子减肥机
CN2045380U (zh) 1989-01-07 1989-10-04 苏州市制冷设备厂 氯气液化装置
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
GB9111426D0 (en) 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5453270A (en) 1992-03-30 1995-09-26 Hypermetabolic Therapies, Inc. Pharmaceutical composition and method for hypermetabolic weight loss
GB9209076D0 (en) 1992-04-27 1992-06-10 Ici Plc Chemical compounds
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
AU7717894A (en) 1993-08-30 1995-03-22 Lipocyte, Inc. Method and composition for weight reduction
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5731408A (en) 1995-04-10 1998-03-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
US5837670A (en) 1995-04-18 1998-11-17 Hartshorn; Richard Timothy Detergent compositions having suds suppressing properties
FR2733513B1 (fr) 1995-04-25 1997-07-18 Centre Nat Rech Scient Lignees immortalisees de cellules issues du tissu adipeux humain, leur procede de preparation et leurs applications
US5789654A (en) 1996-05-09 1998-08-04 Beth Israel Hospital Association Transgenic animals deficient in endogenous β3 -adrenergic receptor and uses thereof
US6246912B1 (en) 1996-06-27 2001-06-12 Sherwood Services Ag Modulated high frequency tissue modification
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
IT1286236B1 (it) 1996-09-24 1998-07-08 Galaxy Top International Spa Procedimento per la stimolazione controllata di regioni predefinite del corpo umano tramite l'applicazione di segnali elettrici variabili
CA2248854C (en) 1996-09-30 2004-03-30 Dennis Jones The regulation of appetite, body weight and athletic function with materials derived from citrus varieties
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
WO1998031396A1 (en) 1997-01-15 1998-07-23 Duke University Respiration uncoupling protein
WO1998045313A1 (en) 1997-04-04 1998-10-15 Amylin Pharmaceuticals, Inc. Novel uncoupling protein and methods of use
US6620594B1 (en) 1997-05-07 2003-09-16 Novartis Ag Uncoupling protein homologue: UCP 3
US6426411B1 (en) 1997-05-30 2002-07-30 Dana-Farber Cancer Institute PGC-1, a novel brown fat pparγ coactivator
US5911992A (en) 1997-06-12 1999-06-15 A. Glenn Braswell Method for controlling weight with hypericum perforatum and garcinia cambogia
SE9702457D0 (sv) 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6072100A (en) 1998-01-28 2000-06-06 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US6450979B1 (en) 1998-02-05 2002-09-17 Miwa Science Laboratory Inc. Ultrasonic wave irradiation apparatus
DE19815411A1 (de) 1998-04-06 1999-10-07 Solvay Pharm Gmbh Thermogenese stimulierend wirksame Arzneimittel
AU4992299A (en) 1998-07-14 2000-02-07 Amylin Pharmaceuticals, Inc. Uncoupling protein 4 (ucp-4) and methods of use
US7599736B2 (en) 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
JP2002523195A (ja) 1998-08-31 2002-07-30 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド ブレードを備える電子輸送装置
US6605297B2 (en) 1998-09-01 2003-08-12 Janiftec, Inc. Substances having antiobese and visceral fat-reducing functions and utilization thereof
US6532286B1 (en) 1998-12-23 2003-03-11 At&T Corp. Method and system for processing a telephone call
FR2788438B1 (fr) 1999-01-14 2003-10-03 Arkopharma Laboratoires Composition pour le traitement de l'obesite et procede de traitement esthetique
US6197580B1 (en) 1999-02-01 2001-03-06 American Home Products Corporation Transcriptional regulation of the human β3-adrenergic receptor gene
WO2000062797A1 (fr) 1999-04-16 2000-10-26 Sumitomo Pharmaceuticals Company, Limited Remedes pour le traitement des neuropathies automatiques
JP3207823B2 (ja) 1999-04-28 2001-09-10 リノール油脂株式会社 共役リノール酸を有効成分とする褐色脂肪増加剤
US7060437B1 (en) 1999-05-05 2006-06-13 Ohio University Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof
JP4155669B2 (ja) 1999-06-14 2008-09-24 独立行政法人科学技術振興機構 植物の発熱関連遺伝子と発熱関連タンパク質
US6548739B2 (en) 1999-06-18 2003-04-15 City Of Hope Method for activating peroxisome proliferator activated receptor-γ
US6445955B1 (en) 1999-07-08 2002-09-03 Stephen A. Michelson Miniature wireless transcutaneous electrical neuro or muscular-stimulation unit
US6607500B2 (en) 1999-07-08 2003-08-19 Cyclotec Advanced Medical Technologies, Inc. Integrated cast and muscle stimulation system
US6381496B1 (en) 1999-10-01 2002-04-30 Advanced Bionics Corporation Parameter context switching for an implanted device
US6207878B1 (en) 1999-10-21 2001-03-27 University Of Iowa Research Foundation Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations
US6983753B1 (en) 1999-11-17 2006-01-10 Smithkline Beecham Corporation Infrared thermography
JP4723707B2 (ja) 1999-12-22 2011-07-13 パナソニック電工株式会社 痩身器具
GB0002059D0 (en) 2000-01-28 2000-03-22 Melacure Therapeutics Ab Novel aromatic amines
JP2001259047A (ja) 2000-03-22 2001-09-25 Matsushita Seiko Co Ltd 体脂肪燃焼方法
EP1268449A4 (en) 2000-03-23 2004-09-15 Merck & Co Inc SUBSTITUTED PIPERIDINE AS MELANOCORTIN RECEPTOR AGONISTS
AU4928101A (en) 2000-03-23 2001-10-03 Merck & Co Inc Spiropiperidine derivatives as melanocortin receptor agonists
US6475530B1 (en) 2000-05-31 2002-11-05 Eric H. Kuhrts Methods and compositions for producing weight loss
AU2001283199A1 (en) 2000-08-08 2002-02-18 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
WO2002015909A1 (en) 2000-08-23 2002-02-28 Merck & Co., Inc. Substituted piperidines as melanocortin receptor agonists
DZ3415A1 (fr) 2000-08-31 2002-03-07 Chiron Corp Guanidinobenzamides comme mc4-r agonistes.
US6895279B2 (en) 2000-09-15 2005-05-17 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Method and apparatus to treat disorders of gastrointestinal peristalsis
US6922590B1 (en) 2000-11-21 2005-07-26 Advanced Bionics Corporation Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
US7440806B1 (en) 2000-11-21 2008-10-21 Boston Scientific Neuromodulation Corp. Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
US7186715B2 (en) 2001-01-08 2007-03-06 Eli Lilly And Company Piperazine- and piperidine-derivatives as melanocortin receptor agonists
CA2435747A1 (en) 2001-01-22 2002-09-06 Genentech, Inc. Bfit (brown fat inducible thioesterase) polypeptides and polynucleotides and their use
US7157463B2 (en) 2001-01-23 2007-01-02 Eli Lilly And Company Substituted piperidines/piperazines as melanocortin receptor agonists
CA2432988A1 (en) 2001-01-23 2002-08-01 Cristina Garcia-Paredes Melanocortin receptor agonists
CA2439149C (en) 2001-02-28 2012-04-24 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
EP1383501B1 (en) 2001-02-28 2007-04-04 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
WO2002067869A2 (en) 2001-02-28 2002-09-06 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
DE60216747T2 (de) 2001-04-09 2007-10-04 Novartis Vaccines and Diagnostics, Inc., Emeryville Guanidinoverbindungen als melanocortin-4-rezeptor (mc4-r) agonisten
US6911447B2 (en) 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
JP2004533297A (ja) 2001-05-29 2004-11-04 メドトロニック・インコーポレーテッド 心臓病の予防及び処置のための閉ループ神経調節システム
JP4495961B2 (ja) 2001-07-05 2010-07-07 ダナ−ファーバー キャンサー インスティテュート インク． 新規なｐｇｃ−１イソフォームおよびその使用
JP2004534851A (ja) 2001-07-11 2004-11-18 パラチン テクノロジーズ インク． メラノコルチン受容体に特異的な線状および環状ペプチド
ATE448481T1 (de) 2001-07-17 2009-11-15 Teijin Ltd Selektionsverfahren für eine durch das austesten einer ppard aktivierenden wirkung charakterisierten substanz und arzneistoff
US7115628B2 (en) 2001-07-18 2006-10-03 Merck & Co., Inc. Bridged piperidine derivatives as melanocortin receptor agonists
US20070162085A1 (en) 2001-07-23 2007-07-12 Dilorenzo Biomedical, Llc Method, apparatus, surgical technique, and stimulation parameters for autonomic neuromodulation for the treatment of obesity
US20090118780A1 (en) 2001-07-23 2009-05-07 Dilorenzo Daniel John Method and apparatus for conformal electrodes for autonomic neuromodulation for the treatment of obesity and other conditions
US6977264B2 (en) 2001-07-25 2005-12-20 Amgen Inc. Substituted piperidines and methods of use
US7115607B2 (en) 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
CA2456331A1 (en) 2001-08-08 2003-02-20 Kevin R. Orton Apparatus and method for electrically conductive weight reduction
AU2002331898A1 (en) 2001-09-24 2003-04-07 Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College Induction of brown adipocytes by transcription factor nfe2l2
US20030082168A1 (en) 2001-10-22 2003-05-01 Inna Yegorova Compositions and methods for facilitating weight loss
US20050080026A1 (en) 2001-10-29 2005-04-14 Arnd Steuernagel Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
WO2003042362A2 (en) 2001-11-09 2003-05-22 Dana-Farber Cancer Institute, Inc. PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
CN2520883Y (zh) 2001-12-11 2002-11-20 中国人民解放军海军潜艇学院 电疗仪
EP1476080A4 (en) 2002-02-20 2010-06-02 Medicis Technologies Corp ULTRASOUND TREATMENT AND COMPOSITE EXPLANATION OF FAT FABRICS
ES2359581T3 (es) 2002-03-15 2011-05-24 The General Hospital Corporation Procedimientos y dispositivos para la rotura selectiva de tejido graso mediante enfriamiento controlado.
US7689277B2 (en) 2002-03-22 2010-03-30 Leptos Biomedical, Inc. Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
WO2003090673A2 (en) 2002-04-22 2003-11-06 Rtc Research & Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
US20040077566A9 (en) 2002-05-09 2004-04-22 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of body weight disorders
US6565847B1 (en) 2002-07-03 2003-05-20 Vitacost.Com, Inc. Thermogenic weight management composition
US7236830B2 (en) 2002-12-10 2007-06-26 Northstar Neuroscience, Inc. Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
WO2004063354A2 (en) 2003-01-10 2004-07-29 The Regents Of The University Of Michigan Compositions and methods for characterizing and regulating wnt pathways
WO2004078716A1 (en) 2003-03-03 2004-09-16 Merck & Co. Inc. Acylated piperazine derivatives as melanocortin-4 receptor agonists
JP4774500B2 (ja) 2003-03-13 2011-09-14 リアル エステテックス リミテッド セルライト超音波処置システム
JP2006521359A (ja) 2003-03-26 2006-09-21 メルク　エンド　カムパニー　インコーポレーテッド メラノコルチン−４受容体作働薬としての二環式ピペリジン誘導体
US7463928B2 (en) 2003-04-25 2008-12-09 Medtronic, Inc. Identifying combinations of electrodes for neurostimulation therapy
DE602004022806D1 (de) 2003-06-04 2009-10-08 Nestec Sa Getränk zur gewichtskontrolle
JP4231349B2 (ja) 2003-07-02 2009-02-25 株式会社ディスコ レーザー加工方法およびレーザー加工装置
US20050136429A1 (en) 2003-07-03 2005-06-23 Massachusetts Institute Of Technology SIRT1 modulation of adipogenesis and adipose function
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
US20050045498A1 (en) 2003-08-25 2005-03-03 Kimberly-Clark Worldwide, Inc. Cold pack
JP3951271B2 (ja) 2003-09-30 2007-08-01 小林製薬株式会社 体脂肪燃焼促進剤
US7576052B2 (en) 2003-10-17 2009-08-18 Joslin Diabetes Center, Inc. Methods and compositions for modulating adipocyte function
WO2005040109A1 (en) 2003-10-22 2005-05-06 Neurocrine Biosciences, Inc. Ligands of melanocortin receptors and compositions and methods related thereto
US8620402B2 (en) 2003-10-30 2013-12-31 Halthion Medical Technologies, Inc. Physiological sensor device
EP1685102A4 (en) 2003-11-12 2008-08-20 Lg Life Sciences Ltd melanocortin
GB0402492D0 (en) 2004-02-04 2004-03-10 Pfizer Ltd Pharmaceutically active compounds
US8165695B2 (en) 2004-02-11 2012-04-24 Ethicon, Inc. System and method for selectively stimulating different body parts
US7979137B2 (en) 2004-02-11 2011-07-12 Ethicon, Inc. System and method for nerve stimulation
US7647112B2 (en) 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
US8751003B2 (en) 2004-02-11 2014-06-10 Ethicon, Inc. Conductive mesh for neurostimulation
JP2007521914A (ja) 2004-02-11 2007-08-09 エシコン・インコーポレイテッド 超小型電子機械システムを用いた尿力学評価方法および評価システム
US7691823B2 (en) 2004-03-05 2010-04-06 University Of Massachusetts RIP140 regulation of glucose transport
US7476406B1 (en) 2004-05-17 2009-01-13 Nse Products, Inc. Multifaceted weight control system
US20060014178A1 (en) 2004-05-26 2006-01-19 Whitson Robert H Use of Mrf-2 for screening and therapies
EP1761303B1 (en) 2004-06-10 2011-09-07 Medtronic Urinary Solutions, Inc. Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence
HUP0401177A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition for increasing the mitochondrial genesis
US20050288740A1 (en) 2004-06-24 2005-12-29 Ethicon Endo-Surgery, Inc. Low frequency transcutaneous telemetry to implanted medical device
US7191007B2 (en) 2004-06-24 2007-03-13 Ethicon Endo-Surgery, Inc Spatially decoupled twin secondary coils for optimizing transcutaneous energy transfer (TET) power transfer characteristics
US7599743B2 (en) 2004-06-24 2009-10-06 Ethicon Endo-Surgery, Inc. Low frequency transcutaneous energy transfer to implanted medical device
US7599744B2 (en) 2004-06-24 2009-10-06 Ethicon Endo-Surgery, Inc. Transcutaneous energy transfer primary coil with a high aspect ferrite core
US20060008540A1 (en) 2004-07-08 2006-01-12 Rulin Xiu Herbal compositions comprising portaluca
CN1984662A (zh) 2004-07-16 2007-06-20 默克公司 用作黑皮质素－4受体激动剂的酰基化哌啶衍生物
AU2005274701A1 (en) 2004-07-19 2006-02-23 Merck Sharp & Dohme Corp. Acylated piperidine derivatives as melanocortin-4 receptor agonists
US20060084637A1 (en) 2004-10-18 2006-04-20 Maria Alemany Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
DE102005000666B3 (de) 2005-01-04 2006-10-05 Sanofi-Aventis Deutschland Gmbh Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20060204599A1 (en) 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
AU2006222983B2 (en) 2005-03-15 2012-08-16 The Regents Of The University Of California Method and system for modulating energy expenditure and neurotrophic factors
AU2006230420B2 (en) 2005-03-31 2011-11-24 Amylin Pharmaceuticals, Llc Compositions and methods for the control, prevention, and treatment of obesity and eating disorders
US7825098B2 (en) 2005-04-04 2010-11-02 Joslin Diabetes Center, Inc. Methods and compositions for modulating Necdin function
US7300409B2 (en) 2005-05-12 2007-11-27 S.C. Johnson & Son, Inc. Therapy patch
US8588930B2 (en) 2005-06-07 2013-11-19 Ethicon, Inc. Piezoelectric stimulation device
WO2006135733A2 (en) 2005-06-10 2006-12-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Modulation of peripheral clocks in adipose tissue
US20080234280A1 (en) 2005-08-01 2008-09-25 Mcmurray Gordon Use of Mc4 Receptor Agonist Compounds
EP1912968A1 (en) 2005-08-04 2008-04-23 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
WO2007026347A1 (en) 2005-09-01 2007-03-08 Power Paper Ltd Double-sided patch
EP1762976B1 (en) 2005-09-08 2011-05-18 Aloka Co., Ltd. Computerized tomography device and image processing method for identifying brown adipose tissue
JP4879988B2 (ja) 2005-09-29 2012-02-22 メルク・シャープ・エンド・ドーム・コーポレイション メラノコルチン−４受容体モジュレーターとしてのアシル化スピロピペリジン誘導体
JP2009510069A (ja) 2005-09-30 2009-03-12 メルク エンド カムパニー インコーポレーテッド メラノコルチン−４受容体作働薬としてのアシル化ピペリジン誘導体
EP1940401B1 (en) 2005-10-18 2012-07-11 Merck Sharp & Dohme Corp. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
US9061146B2 (en) 2005-10-28 2015-06-23 Medtronic, Inc. Impedance-based bladder sensing
US20070282318A1 (en) 2006-05-16 2007-12-06 Spooner Gregory J Subcutaneous thermolipolysis using radiofrequency energy
CN2899835Y (zh) 2006-05-18 2007-05-16 陕西秦明医学仪器股份有限公司 植入式减肥刺激器
US20080262411A1 (en) 2006-06-02 2008-10-23 Dobak John D Dynamic nerve stimulation in combination with other eating disorder treatment modalities
US7264602B1 (en) 2006-06-28 2007-09-04 Longsworth Sheryl M Bandage assembly
US7623278B2 (en) 2006-09-26 2009-11-24 Xerox Corporation MEMS Fabry-Perot inline color scanner for printing applications using stationary membranes
US8209037B2 (en) 2006-10-04 2012-06-26 Ethicon Endo-Surgery, Inc. Methods and devices for medical treatment
US9074012B2 (en) 2006-10-18 2015-07-07 Dana-Farber Cancer Institute, Inc. Molecular control of brown fat differentiation and energy expenditure
US20080132962A1 (en) 2006-12-01 2008-06-05 Diubaldi Anthony System and method for affecting gatric functions
WO2008067639A1 (en) 2006-12-06 2008-06-12 H3 Formulations Ltd. Composition for promoting weight loss comprising yohimbine, evodia rutaecarpia extract and l-carnitine
US8128576B2 (en) 2006-12-07 2012-03-06 Ethicon, Inc. System and method for urodynamic evaluation utilizing micro electro-mechanical system technology
US8175718B2 (en) 2006-12-19 2012-05-08 Ethicon, Inc. Electrode patch and method for neurostimulation
WO2008085290A2 (en) 2006-12-28 2008-07-17 Vibrynt, Inc. Devices and methods for treatment of obesity
EP2106406A2 (en) 2007-01-18 2009-10-07 Novo Nordisk A/S Novel peptides for use in the treatment of obesity
US20100022446A1 (en) 2007-01-18 2010-01-28 Novo Nordisk A/S Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
US7815895B2 (en) 2007-05-21 2010-10-19 Tohoku University Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith
EP2170338A2 (en) 2007-07-06 2010-04-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dna-pkcs modulates energy regulation and brain function
US8103355B2 (en) 2007-07-16 2012-01-24 Invasix Ltd Method and device for minimally invasive skin and fat treatment
US20090024144A1 (en) 2007-07-18 2009-01-22 Zeiner Mark S Hybrid endoscopic/laparoscopic device for forming serosa to serosa plications in a gastric cavity
US20090081715A1 (en) 2007-09-07 2009-03-26 Cobalt Technologies, Inc., A Delaware Corporation Engineered Light-Emitting Reporter Genes
US9529972B2 (en) 2007-09-24 2016-12-27 Medtronic, Inc. Patient event indication
US8352026B2 (en) 2007-10-03 2013-01-08 Ethicon, Inc. Implantable pulse generators and methods for selective nerve stimulation
US8162530B2 (en) 2007-10-05 2012-04-24 Main Power Electrical Factory Ltd. Handheld electric mixer
US8260439B2 (en) 2007-11-16 2012-09-04 Ethicon, Inc. Nerve stimulation patches and methods for stimulating selected nerves
WO2009067501A2 (en) 2007-11-19 2009-05-28 Joslin Diabetes Center, Inc. Infrared thermography for monitoring brown adipose tissue
US20090149918A1 (en) 2007-12-06 2009-06-11 Peter Krulevitch Implantable antenna
JP5189654B2 (ja) 2007-12-12 2013-04-24 カーディアック ペースメイカーズ， インコーポレイテッド 肺動脈から神経刺激を伝達する刺激システム
US8170683B2 (en) 2007-12-14 2012-05-01 Ethicon, Inc. Dermatome stimulation devices and methods
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8565885B2 (en) 2008-01-30 2013-10-22 The Board Of Regents Of The University Of Texas System Ileal electrical stimulation
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8057492B2 (en) 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
CA2718708A1 (en) 2008-03-17 2009-09-24 Geisinger Clinic Genetic indicators of weight loss
US20100056948A1 (en) 2008-08-26 2010-03-04 Hornby Pamela J Stimulation of Satiety Hormone Release
US7818060B2 (en) 2008-10-31 2010-10-19 Medtronic, Inc. Determination of stimulation output capabilities throughout power source voltage range
US8897885B2 (en) 2008-12-19 2014-11-25 Ethicon, Inc. Optimizing the stimulus current in a surface based stimulation device
US7970478B2 (en) 2008-12-19 2011-06-28 Ethicon, Inc. Optimizing stimulation therapy of an external stimulating device based on firing of action potential in target nerve
US8303982B2 (en) 2009-03-20 2012-11-06 Ethicon, Inc Self-locating, multiple application, and multiple location medical patch systems and methods therefor
US8340772B2 (en) 2009-05-08 2012-12-25 Advanced Neuromodulation Systems, Inc. Brown adipose tissue utilization through neuromodulation
US20110000270A1 (en) 2009-06-18 2011-01-06 Organic Green Solutions, Inc. Organic slurry compositions and method of application
US8126530B2 (en) 2009-10-26 2012-02-28 Ethicon, Inc. Offset electrode
US20110144490A1 (en) 2009-12-10 2011-06-16 General Electric Company Devices and methods for adipose tissue reduction and skin contour irregularity smoothing
US9220885B2 (en) 2009-12-18 2015-12-29 Ethicon, Inc. Placement devices that enable patients to accurately position medical patches at target locations and methods therefor
US9044606B2 (en) * 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US20120165792A1 (en) 2010-12-22 2012-06-28 Ethicon Endo-Surgery, Inc. Pill Catchers
US9610429B2 (en) 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
WO2012092057A1 (en) 2010-12-29 2012-07-05 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with light
US8696616B2 (en) 2010-12-29 2014-04-15 Ethicon Endo-Surgery, Inc. Obesity therapy and heart rate variability
US9381219B2 (en) 2010-12-29 2016-07-05 Ethicon Endo-Surgery, Inc. Brown adipocyte modification
US20120172783A1 (en) 2010-12-29 2012-07-05 Ethicon Endo-Surgery, Inc. Obesity therapy and heart rate variability
US10441459B2 (en) 2010-12-29 2019-10-15 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with cooling
FR2972942B1 (fr) 2011-03-21 2017-11-24 Arkema France Procede de fabrication de nanotubes de carbone et appareil pour la mise en oeuvre du procede.
US8968377B2 (en) * 2011-05-09 2015-03-03 The Invention Science Fund I, Llc Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject
US9314609B2 (en) 2011-10-28 2016-04-19 Martin Brown Device for providing electrical stimulation of a human knee
JP2013126486A (ja) 2011-12-19 2013-06-27 Panasonic Corp 電気刺激装置
US20130209418A1 (en) * 2012-02-15 2013-08-15 Johnson & Johnson Regenerative Therapeutics, Llc Methods and composition related to brown adipose-like cells
US8812100B2 (en) 2012-05-10 2014-08-19 Ethicon Endo-Surgery, Inc. Device and method for self-positioning of a stimulation device to activate brown adipose tissue depot in a supraclavicular fossa region
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue

Also Published As

Publication number Publication date
US10960201B2 (en) 2021-03-30
EP3240606A1 (en) 2017-11-08
CN107278161B (zh) 2021-07-16
JP2018501069A (ja) 2018-01-18
JP6668379B2 (ja) 2020-03-18
US10092738B2 (en) 2018-10-09
CN107278161A (zh) 2017-10-20
BR112017013892B1 (pt) 2022-11-08
EP3240606B1 (en) 2022-11-16
US20160184568A1 (en) 2016-06-30
US20210205608A1 (en) 2021-07-08
US20180369549A1 (en) 2018-12-27
WO2016109169A1 (en) 2016-07-07

Similar Documents

Publication Publication Date Title
BR112017013892A2 (pt) métodos e dispositivos para inibir nervos ao ativar o tecido adiposo marrom
BR112017004047A2 (pt) sistema e método para bloquear seletivamente a atividade de fibra nervosa
CY1123678T1 (el) Χρηση αναστολεων μυοστατινης και θεραπειες συνδυασμου
BR112016016007A2 (pt) Determinação de local interno que usa compatibilidade de padrão de dispositivos ponto a ponto
TR201902630T4 (tr) Raylı taşıtların tekerlek takımları için tekerlek takımı ölçüm tertibatı.
BR112016030690A2 (pt) moduladores do receptor de arila e métodos de fabricar e usar os mesmos
EA201691619A1 (ru) Конденсированные гетероциклические соединения
BR112015017241A2 (pt) doadores de nitroxil com índice terapêutico melhorado
BR112016026264A2 (pt) sistema e método dos mesmos para otimizar o tempo de inicialização de computadores com múltiplas cpus.
BR112017005646A2 (pt) funções de partição composta
EP3116593A4 (en) Systems and methods for neuromodulation of sympathetic and parasympathetic cardiac nerves
BR112018002077A2 (pt) sistema de perfuração de fundo de poço e capacitor
BR112017003163A2 (pt) dispositivo de infraestrutura modular, sistema de infraestrutura e processo para operação de um dispositivo de infraestrutura
CL2014001842A1 (es) Separación de dióxido de carbono que implica procesos termolíticos basados en dos sales.
MX2016009630A (es) Compuestos inmunomoduladores.
BR112016015394A8 (pt) sistemas de geração de pulso elétrico
BR112015029108A2 (pt) sistemas de armazenamento e memória "aliased
BR112017013125A2 (pt) método e dispositivo para configuração de dispositivo
BR112017018068A2 (pt) dispositivo de neuromodulação
AR100481A1 (es) Proceso para la remoción de agua (tanto ligada como no ligada) a partir de lodos y emulsiones de petróleo con el objeto de recuperar los hidrocarburos originales presentes en los mismos
BR112016002692A2 (pt) reator de carbonização para materiais de hidrocarboneto com veículo de calor sólido e método de carbonização baseado no reator de carbonização.
BR112017000490A2 (pt) componente condutor de fluxo
BR112018076979A2 (pt) separação de hidrocarbonetos de matéria particulada usando sal e polímero
BR112016029905A2 (pt) adesivos transponíveis sensíveis à pressão, artigos e métodos relacionados
BR112017011112A2 (pt) sistema de injeção de salmoura

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/12/2015, OBSERVADAS AS CONDICOES LEGAIS